Atomi Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$346K Buy
5,131
+848
+20% +$56.5K 0.01% 955
2026
Q1
$269K Buy
4,283
+1,066
+33% +$74.2K 0.01% 1010
2025
Q4
$213K Sell
3,217
-763
-19% -$49.3K 0.01% 1120
2025
Q3
$268K Sell
3,980
-2,222
-36% -$176K 0.01% 955
2025
Q2
$541K Buy
6,202
+2,431
+64% +$191K 0.02% 555
2025
Q1
$257K Sell
3,771
-1,603
-30% -$131K 0.01% 851
2024
Q4
$418K Buy
5,374
+1,438
+37% +$106K 0.02% 554
2024
Q3
$264K Buy
+3,936
New +$323K 0.02% 730

Other funds holding DXCM

Atomi Financial Group's DXCM Position: Q2 2026 in Review

Atomi Financial Group increased its DexCom (DXCM) stake by 20% in Q2 2026, buying an estimated $56.5K and bringing the position to 5,131 shares worth $346K. The position accounts for 0.01% of the portfolio, ranked #955.

Atomi Financial Group first reported a position in DXCM in Q3 2024 and has held it in 8 quarters since. The position peaked at $541K in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Atomi Financial Group held 5,131 shares of DexCom worth $346K as of Q2 2026.
  • Atomi Financial Group bought 848 DexCom shares in Q2 2026, an estimated $56.5K.
  • DexCom made up 0.01% of Atomi Financial Group's portfolio in Q2 2026, its #955 holding.
  • Atomi Financial Group first reported a position in DexCom in Q3 2024 and has held it in 8 quarters since.
  • Atomi Financial Group's DexCom position peaked at $541K in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.